Genetic Technologies (GENE) Fails to deliver data

Key failure to deliver metrics for Genetic Technologies:

• Last SEC data release: 2025-09-30
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: £0 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Genetic Technologies (GENE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Genetic Technologies (GENE) - since 2023

Genetic Technologies (GENE) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Thermo Fisher Scientific TMO	£4.93 M	£58.59 M	🇺🇸 USA
Quest Diagnostics DGX	£26 M	£60.6 M	🇺🇸 USA
Danaher DHR	£4.09 M	£0.16 B	🇺🇸 USA
LabCorp LH	£8.97 M	£30.39 M	🇺🇸 USA
Compugen CGEN	£0.45 M	£1.2 M	🇮🇱 Israel
Neogen NEOG	£6.05 M	£29.39 M	🇺🇸 USA
Myriad Genetics MYGN	£0.03 M	£0.83 M	🇺🇸 USA
Eterna Therapeutics ERNA	N/A	£0.05 M	🇺🇸 USA